The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 12-18 May 2019 and includes updates on poliomyelitis, chikungunya virus disease and dengue, measles, monkeypox, dengue, Ebola virus disease, influenza, Rift Valley fever, Crimean-Congo haemmorhagic fever and Legionnaires' disease.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 21–27 April 2019 and includes updates on influenza A(H7N9), chikungunya and dengue, dengue, Ebola virus disease, influenza, Rift Valley fever and risks of communicable diseases related to Cyclone Idai.